CRISPR’s reputation was tarnished last year after a researcher in China edited a gene in embryos that went on to develop into two baby girls. The current CRISPR trials don’t have the same ethical challenges — the therapies won’t lead to DNA changes that can be inherited, says Alan Regenberg, Still, he says, there’s reason for caution when working with humans

Quick Read

A profound breach of that trust occurs when those professionals not only violate the “do no harm” maxim they pledged when taking the Hippocratic oath, but do so through the misuse of the licenses and privileges they’ve been granted in exchange for our trust. That’s happening right now on our southern border

Quick Read

Some scientists say it should be. “As a matter of truth in advertising, the ‘finished’ sequence isn’t finished,” said Eric Lander, who led the lab at the Whitehead Institute that deciphered more of the genome for the government-funded Human Genome Project than any other. “I always say ‘finished’ is a term of art.”

Quick Read